StudyRareStudyRare

Fatty acid beta-oxidation

Log in to star
Fat and ketone metabolism

Last updated Nov 4, 2026

Log in to add personal notes on this page.

Beta-oxidation breaks fatty acids down inside mitochondria, two carbons per turn, into acetyl-CoA for the Krebs cycle and, in the liver, for ketone bodies. Each turn has four steps, and the first is done by one of four acyl-CoA dehydrogenases matched to chain length: very long-chain (14 to 20 carbons), long-chain (10 to 14), medium-chain (6 to 10), or short-chain (4 to 6). The figure draws the very long-, medium-, and short-chain steps. Long-chain fats enter on the carnitine shuttle; medium-chain fats diffuse in without it. Heart, skeletal muscle, and the fasting liver depend most on this pathway, so they show the failures.

very long-chain acyl-CoAdehydrogenaseACADVL; electrons to FADVLCAD deficiencyhydratase, trifunctional proteinalpha subunitHADHAtrifunctional protein deficiencylong-chain 3-hydroxyacyl-CoAdehydrogenase, alpha subunitHADHALCHAD deficiencytrifunctional protein deficiencythiolase, trifunctional proteinbeta subunitHADHBtrifunctional protein deficiencyeach turn shortens the chain bytwo carbonsmedium-chain acyl-CoAdehydrogenaseACADMMCAD deficiencythe three later steps of eachturn, by medium- and short-chainenzymes in the mitochondrialmatrixshort-chain acyl-CoA dehydrogenaseACADSSCAD deficiencyelectron transfer flavoprotein andETF dehydrogenaseETFA, ETFB, ETFDH;FAD-dependentmultiple acyl-CoA dehydrogenasedeficiencylong-chain acyl-CoA(14 to 20 carbons)long-chain enoyl-CoA3-hydroxyacyl-CoA3-ketoacyl-CoAacetyl-CoA + acyl-CoAtwo carbons shortermedium-chain acyl-CoA(6 to 10 carbons)medium-chain enoyl-CoAshort-chain acyl-CoA(4 to 6 carbons)short-chain enoyl-CoAelectrons from eachdehydrogenasecoenzyme Q, respiratorychain
Figure: one turn of long-chain beta-oxidation, then the medium- and short-chain first steps and the shared electron transfer, with the six disorders at the steps they block.
  1. long-chain acyl-CoA (14 to 20 carbons) → long-chain enoyl-CoA: very long-chain acyl-CoA dehydrogenase (ACADVL), passing electrons to FAD. Blocked in VLCAD deficiency.
  2. long-chain enoyl-CoA → 3-hydroxyacyl-CoA → 3-ketoacyl-CoA → acetyl-CoA + an acyl-CoA two carbons shorter: mitochondrial trifunctional protein, whose alpha subunit (HADHA) carries the hydratase and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and whose beta subunit (HADHB) carries the thiolase. Blocked in LCHAD deficiency (the dehydrogenase only) and trifunctional protein deficiency (all three).
  3. medium-chain acyl-CoA (6 to 10 carbons) → medium-chain enoyl-CoA: medium-chain acyl-CoA dehydrogenase (ACADM). Blocked in MCAD deficiency.
  4. short-chain acyl-CoA (4 to 6 carbons) → short-chain enoyl-CoA: short-chain acyl-CoA dehydrogenase (ACADS). Blocked in SCAD deficiency.
  5. Electrons from every dehydrogenase → coenzyme Q: electron transfer flavoprotein (ETFA, ETFB) and ETF dehydrogenase (ETFDH), FAD-dependent. Blocked in multiple acyl-CoA dehydrogenase deficiency.
  • VLCAD deficiency: the long-chain spiral cannot start. C14:1 is the newborn screening marker. Severe early disease brings cardiomyopathy and arrhythmia; milder forms bring hypoketotic hypoglycemia or exercise rhabdomyolysis.
  • LCHAD deficiency: 3-hydroxy intermediates build up as C16-OH and C18:1-OH. Retinopathy and neuropathy follow, and a pregnancy carrying an affected fetus can be complicated by HELLP syndrome or acute fatty liver.
  • Trifunctional protein deficiency: the same acylcarnitines as LCHAD deficiency; more often severe neonatal disease, less often retinopathy. An enzyme assay separates the two.
  • MCAD deficiency: medium-chain fats cannot become acetyl-CoA. C8 (octanoylcarnitine) is the marker. A well child is covered by glycogen; fasting or illness brings hypoketotic hypoglycemia, coma, and sudden death.
  • SCAD deficiency: C4 and urine ethylmalonic acid rise, but no clinical disease has held up in unbiased studies; it is a laboratory finding.
  • MADD: every linked dehydrogenase stalls, so acylcarnitines rise at all chain lengths and urine carries glutaric and ethylmalonic acids. Late-onset forms usually respond to riboflavin.
  • Hypoketotic hypoglycemia is the shared signature: without acetyl-CoA from fat, the fasting body has neither glucose nor ketones.
  • The acylcarnitine chain length names the enzyme: C14:1 for VLCAD, C16-OH for LCHAD and trifunctional protein, C8 for MCAD, C4 for SCAD, every length at once for MADD.
  • Long-chain defects are more severe and earlier than MCAD deficiency, because long-chain fat is blocked at its first step while medium-chain fat has already been partly broken down upstream. Long-chain acylcarnitines are also toxic to heart and muscle. That is why medium-chain triglyceride oil, which skips the long-chain steps, helps long-chain defects.